About the story
Original article
Translated from the original publication. Dates and historical information are retained.
Written for Kunnskapsbanken:
This note focuses on possible consequences for infection transmission and the ability to treat patients, in light of measures implemented in Norway and subsequently across much of the world.
Prime Minister Erna Solberg recently stressed the need for measures against coronavirus to “avoid excessively steep peaks in the infection curve”. The more people become ill simultaneously, the greater the pressure on healthcare. This risks deaths that could otherwise have been avoided.
Measures that slow transmission mean fewer people need help at once and increase the likelihood that everyone receives help when they need it.
The measures being introduced are undoubtedly extremely costly for society, and no one knows the final cost. Nor do we know what less drastic measures would have cost.
This note examines possible effects on transmission and the capacity to treat patients, based on measures introduced in Norway and subsequently in much of the world.
A real-world example compares infections in China’s Hubei province, where the virus emerged, with neighbouring Henan. We use Johns Hopkins University data. In Hubei, infection had spread considerably further than in Henan before China introduced drastic measures to limit transmission.
Source: Capia/Kunnskapsbanken.
The differences are extreme. Death counts illustrate them too; the figure shows cumulative deaths.
Source: Capia/Kunnskapsbanken. The difference illustrates the consequences of acting early. Henan, with 94 million residents, and Hubei, with 58.5 million, are both large provinces. Relative to their populations, only a very small proportion have died from the virus. According to Johns Hopkins University, Hubei’s death toll is just over 3,000, only 0.005 per cent of its population. Nevertheless, the figure illustrates the impact of early transmission-control measures.
A diagram illustrating the effect of measures against transmission has been widely shared on social media and in the news in recent days, in several versions, often under #FlattenTheCurve.
It shows two things: first, healthcare has limited capacity, represented by the horizontal dashed line; second, measures that spread illness over a longer period increase the likelihood that everyone needing help receives it. Both points are correct. The diagram is, however, greatly simplified, as we explore here.
The first and perhaps most obvious simplification is its assumption of constant healthcare capacity throughout the outbreak, shown by the straight dashed line. Without measures—the red curve—many healthcare workers will also become ill. Capacity will therefore be lowest precisely when the outbreak is strongest. Everyone needing healthcare will then struggle to obtain it, not only coronavirus patients.
In Wuhan, Hubei’s capital and the city where the outbreak began, as many as 63 per cent of tested healthcare workers were infected. Elsewhere in China, infection among healthcare workers was much lower, at 3.8 per cent, helped significantly by infection-control measures introduced as knowledge of the outbreak spread.
This leads to the next simplification: what will actually happen to healthcare capacity when numerous transmission-control measures are implemented in Norway and elsewhere?
With measures in place, healthcare capacity will not be a straight line either.
“We need time.” — Massimo Puoti, head of infectious diseases at Niguarda Hospital in Milan.
Norway and many other countries are now implementing extreme measures to slow transmission. This buys time to produce and distribute equipment to treat patients and protect healthcare staff—equipment urgently needed worldwide.
“Test, test, test.” — Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization.
The same applies to coronavirus testing equipment, which Norway and most other countries currently reserve for people meeting certain criteria. Everything is connected: the more infected people there are, the harder it is to identify and isolate further transmission. This increases the likelihood that home-care workers, nursing-home staff, hospital staff and other healthcare workers become infected and transmit the disease to precisely those who most need protection. As test equipment is scarce in many countries, we are buying time to increase testing capacity—an extremely important part of limiting spread.
We also buy time to recruit available healthcare staff and learn which medicines and treatments work best. We buy time to organise care so as to minimise transmission among coronavirus patients and between staff and patients requiring treatment for other reasons. Further ahead, a vaccine may be developed, which would clearly be valuable in stopping transmission.
A modified version of the diagram above illustrates the effect of all measures that delay spread.
We still do not know whether we are buying enough time to ensure adequate treatment for everyone, or which measures are most effective. What we do know is that time has rarely been more valuable than it is right now.
Sources and references
- regjeringen.no — reference (source in Norwegian)
- github.com — reference
- coronavirus.jhu.edu — reference
- twitter.com — reference
- medium.com — reference
- jamanetwork.com — reference
- nytimes.com — reference
- vg.no — reference (source in Norwegian)
- who.int — reference
- reuters.com — reference
- fhi.no — reference (source in Norwegian)
- twitter.com — reference
Historical context
This story is based on an earlier publication. It describes the work and data at that time and is not an updated market report.
